SCHEMBL21362533

SCHEMBL21362533

C=Cc1ccc(C(=O)c2ccc(CBr)cc2Br)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACHE P22303 8/20 0.43
ALDH1A1 P00352 2/20 0.43
BCHE P06276 5/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
HPGD P15428 2/20 0.39
CYP2D6 P10635 1/20 0.39
SLC22A6 Q4U2R8 1/20 0.38
SLC22A8 Q8TCC7 1/20 0.38
NPC1 O15118 1/20 0.37
PTPN1 P18031 3/20 0.37
KMT2A Q03164 1/20 0.36
LSS P48449 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
SMPD1 P17405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362791 0.85 ALDH1A1 (0.44) ACHEALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL20157609 0.84 ALDH1A1 (0.46) ACHEALDH1A1BCHECYP1A2CYP2C19
SCHEMBL20157608 0.83 ALDH1A1 (0.44) ACHEALDH1A1BCHECYP1A2CYP2C19
SCHEMBL21550017 0.83 ALDH1A1 (0.44) ACHEALDH1A1BCHECYP1A2CYP2C19
SCHEMBL20158040 0.81 ACHE (0.54) ACHEALDH1A1BCHECYP1A2CYP2C19
SCHEMBL20157412 0.78 NPC1 (0.54) ACHEALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL20157472 0.78 CES2 (0.38) ALDH1A1HPGDPTPN1KMT2ALSS
SCHEMBL21362523 0.78 ACHE (0.33) ACHEALDH1A1BCHEPTPN1LSS
SCHEMBL14760747 0.77 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP3A4TSHRNPC1
SCHEMBL21362793 0.74 PKM (0.49) ACHEALDH1A1BCHECYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed